Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein - PubMed (original) (raw)
. 2003 Dec 26;278(52):52660-72.
doi: 10.1074/jbc.M308036200. Epub 2003 Sep 30.
Affiliations
- PMID: 14523016
- DOI: 10.1074/jbc.M308036200
Free article
Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein
Jian Fu et al. J Biol Chem. 2003.
Free article
Abstract
X-linked inhibitor of apoptosis protein (XIAP), the most potent member of the inhibitor of apoptosis protein (IAP) family, plays a crucial role in the regulation of apoptosis. XIAP is structurally characterized by three baculovirus IAP repeat (BIR) domains that mediate binding to and inhibition of caspases and a RING domain that confers ubiquitin ligase activity. The caspase inhibitory activity of XIAP can be eliminated by the second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low pI (DIABLO) during apoptosis. Here we report the identification and characterization of a novel isoform of Smac/DIABLO named Smac3, which is generated by alternative splicing of exon 4. Smac3 contains an NH2-terminal mitochondrial targeting sequence required for mitochondrial targeting of Smac3 and an IAP-binding motif essential for Smac3 binding to XIAP. Smac3 is released from mitochondria into the cytosol in response to apoptotic stimuli, where it interacts with the second and third BIR domains of XIAP. Smac3 disrupts processed caspase-9 binding to XIAP, promotes caspase-3 activation, and potentiates apoptosis. Strikingly, Smac3, but not Smac/DIABLO, accelerates XIAP auto-ubiquitination and destruction. Smac3-stimulated XIAP ubiquitination is contingent upon the physical association of XIAP with Smac3 and an intact RING domain of XIAP. Smac3-accelerated XIAP destabilization is, at least in part, attributed to its ability to enhance XIAP ubiquitination. Our study demonstrates that Smac3 is functionally additive to, but independent of, Smac/DIABLO.
Similar articles
- Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition.
Wilkinson JC, Wilkinson AS, Scott FL, Csomos RA, Salvesen GS, Duckett CS. Wilkinson JC, et al. J Biol Chem. 2004 Dec 3;279(49):51082-90. doi: 10.1074/jbc.M408655200. Epub 2004 Sep 15. J Biol Chem. 2004. PMID: 15371416 - Smac/Diablo antagonizes ubiquitin ligase activity of inhibitor of apoptosis proteins.
Creagh EM, Murphy BM, Duriez PJ, Duckett CS, Martin SJ. Creagh EM, et al. J Biol Chem. 2004 Jun 25;279(26):26906-14. doi: 10.1074/jbc.M313859200. Epub 2004 Apr 12. J Biol Chem. 2004. PMID: 15078891 - Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D, Franklin MC, Wallweber HJ, Das K, Eckelman BP, Shin H, Elliott LO, Kadkhodayan S, Deshayes K, Salvesen GS, Fairbrother WJ. Vucic D, et al. Biochem J. 2005 Jan 1;385(Pt 1):11-20. doi: 10.1042/BJ20041108. Biochem J. 2005. PMID: 15485396 Free PMC article. - Smac/DIABLO and colon cancer.
Anguiano-Hernandez YM, Chartier A, Huerta S. Anguiano-Hernandez YM, et al. Anticancer Agents Med Chem. 2007 Jul;7(4):467-73. doi: 10.2174/187152007781058631. Anticancer Agents Med Chem. 2007. PMID: 17630921 Review. - Targeting XIAP for Promoting Cancer Cell Death-The Story of ARTS and SMAC.
Abbas R, Larisch S. Abbas R, et al. Cells. 2020 Mar 9;9(3):663. doi: 10.3390/cells9030663. Cells. 2020. PMID: 32182843 Free PMC article. Review.
Cited by
- Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer.
Mizutani Y, Katsuoka Y, Bonavida B. Mizutani Y, et al. Int J Oncol. 2012 Apr;40(4):1246-50. doi: 10.3892/ijo.2012.1324. Epub 2012 Jan 3. Int J Oncol. 2012. PMID: 22218530 Free PMC article. - Daxx-beta and Daxx-gamma, two novel splice variants of the transcriptional co-repressor Daxx.
Wethkamp N, Hanenberg H, Funke S, Suschek CV, Wetzel W, Heikaus S, Grinstein E, Ramp U, Engers R, Gabbert HE, Mahotka C. Wethkamp N, et al. J Biol Chem. 2011 Jun 3;286(22):19576-88. doi: 10.1074/jbc.M110.196311. Epub 2011 Apr 10. J Biol Chem. 2011. PMID: 21482821 Free PMC article. - Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein.
NeMoyer R, Mondal A, Vora M, Langenfeld E, Glover D, Scott M, Lairson L, Rongo C, Augeri DJ, Peng Y, Jabbour SK, Langenfeld J. NeMoyer R, et al. Cell Commun Signal. 2019 Nov 19;17(1):150. doi: 10.1186/s12964-019-0469-5. Cell Commun Signal. 2019. PMID: 31744505 Free PMC article. No abstract available. - Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
Chen S, Wang Y, Pan Y, Liu Y, Zheng S, Ding K, Mu K, Yuan Y, Li Z, Song H, Jin Y, Fu J. Chen S, et al. J Am Heart Assoc. 2020 Jun 16;9(12):e015513. doi: 10.1161/JAHA.119.015513. Epub 2020 Jun 1. J Am Heart Assoc. 2020. PMID: 32476536 Free PMC article. - Role of Smac/DIABLO in cancer progression.
Martinez-Ruiz G, Maldonado V, Ceballos-Cancino G, Grajeda JP, Melendez-Zajgla J. Martinez-Ruiz G, et al. J Exp Clin Cancer Res. 2008 Sep 26;27(1):48. doi: 10.1186/1756-9966-27-48. J Exp Clin Cancer Res. 2008. PMID: 18822137 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous